A Quote by Mark Walport

We all want our drugs to be safe - and so an essential part of the pathway to the development of a new drug is approval by a regulator. — © Mark Walport
We all want our drugs to be safe - and so an essential part of the pathway to the development of a new drug is approval by a regulator.
Pharmacogenomics holds great promise to shed scientific light on the often risky and costly process of drug development, and to provide greater confidence about the risks and benefits of drugs in specific populations. Pharmacogenomics is a new field, but we intend to do all we can to use it to promote the development of medicines. By providing practical guidance on how to turn the explosion of pharmacogenomic information into real evidence on new drugs, we are taking an important step toward that goal.
Various species of animals react differently to the same drug. Not only do the variations in the metabolism of a drug make it difficult to extrapolate results of animal experiments to man but they create a serious obstacle to the development of new therapeutic drugs.
We've got to get our drug industry back. Our drug industry has been disastrous. They're leaving left and right. They supply our drugs, but they don't make them here, to a large extent. And the other thing we have to do is create new bidding procedures for the drug industry because they're getting away with murder.
Consider the clinicaltrials by which drugs are tested in human subjects.5 Before a new drug can enter the market, its manufacturer must sponsor clinicaltrials to show the Food and Drug Administration that the drug is safe and effective, usually as compared with a placebo or dummy pill. The results of all the trials (there may be many) are submitted to the FDA, and if one or two trials are positive—that is, they show effectiveness without serious risk—the drug is usually approved, even if all the other trials are negative.
Patients who face long odds and terminal illnesses do not always have access to the latest drugs in clinical trials. They don't want to give up, but they don't have years to wait for new drugs to receive FDA approval.
"Drugs" are not necessarily narcotics. The narcotic is one type of drug and coffee is a drug... booze is a drug... many drugs.... They're all around us.
As a mother of four children, I want to know the drugs I'm giving them are safe. And as an American businesswoman, I want to keep jobs here, and that means making sure foreign drug plants have to meet the same standards as domestic ones.
As a former professional patient advocate, I believe prescription drugs are an essential part of high-quality medical treatment, and I supported enactment of the Medicare Prescription Drug and Modernization Act.
Scheduling of drugs is a government problem, not our problem. They want to schedule something, that's their problem. My feeling of creation is to make new drugs. They're new drugs, so they're unscheduled. They've never been made before.
For all of life's discontents, according to the pharmaceutical industry, there is a drug and you should take it. Then for the side effects of that drug, then there's another drug, and so on. So we're all taking more drugs, and more expensive drugs.
One of the things that has happened is that our drug laws have been institutionalized now. If you want to say that somebody's a bad person in a movie or in a television show or something about that, you say they sell drugs or they use drugs.
The purpose of our journey on this precious Earth is now to align our personalities with our souls and the souls of others. It is to create harmony, cooperation, sharing, and reverence for Life. It is to grow spiritually. This is our new evolutionary pathway. The old pathway - pursuing the ability to manipulate and control - no longer works.
I get frustrated with people who say that a drug experience can have no spiritual validity. I'm here to tell you that all experience is a drug experience. We're all on drugs all the time, largely because we are MADE of drugs
While I recognize the great value and importance of prescription drugs and strongly support a continued U.S. focus on pharmaceutical research and development, our nation's seniors cannot be asked to subsidize the drug costs of other wealthy industrialized nations any longer.
They said I ignored the drug problem. Well, I gave speeches on drugs, I wrote books on drugs. I did darn near everything on drugs!
Drug companies spend more on advertising and marketing than on research, more on research on lifestyle drugs than on life saving drugs, and almost nothing on diseases that affect developing countries only. This is not surprising. Poor people cannot afford drugs, and drug companies make investments that yield the highest returns.
This site uses cookies to ensure you get the best experience. More info...
Got it!